Drug therapy for Parkinson&rsquo;s disease: An update

doi:10.5497/wjp.v4.i1.117

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12052)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

844

WORD

413

HTML

8049

Figures (1-2)

325

Tables (1-2)

264

Sum=9895

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

827

Download

1330

Sum=2157

Mar 9, 2015 (publication date) through Jan 23, 2025

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Pharmacology

ISSN

2220-3192

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Pharmacol. Mar 9, 2015; 4(1): 117-143
Published online Mar 9, 2015. doi: 10.5497/wjp.v4.i1.117

Open in New Tab Full Size Figure Download Figure

Figure 1 Site of action of antiparkinsonian drugs. DA: Dopamine; DOPAC: Dihydroxyphenylacetic acid; MAO-B: Monoamine oxidase-B; L-dopa: Levodopa; COMT: Catechol-O-methyltransferase.

Open in New Tab Full Size Figure Download Figure

Figure 2 Drugs used to treat Parkinson’s disease. L-dopa: Levodopa; PD: Parkinson’s disease; MAO-B: Monoamine oxidase type B; COMT: Catechol-O-methyltransferase.

Citation: Abdel-Salam OM. Drug therapy for Parkinson’s disease: An update. World J Pharmacol 2015; 4(1): 117-143
URL: https://www.wjgnet.com/2220-3192/full/v4/i1/117.htm
DOI: https://dx.doi.org/10.5497/wjp.v4.i1.117